Results Revenues

 
News Articles for Results Revenues top ^
Concordia Healthcare Announces Third Quarter Results - Revenue up 147%, EBITDA up 80% Over Comparative Period Canada NewsWire Third Quarter 2014 Highlights Third quarter, 2014 revenue increase of 147 per cent compared to the third quarter of 2013; Third quarter, 2014 adjusted EBITDA up 137 per cent versus the same period in 2013; On September 30, 2014 , the Company announced its subsidiary, Concordia Pharmaceuticals Inc. (CPI), completed the acquisition of Zonegran® (zonisamide) for commercialization and sale in the United States , including Puerto Rico .
Sign-up for Concordia Healthcare Announces Third Quarter Results - Revenue up 147%, EBITDA up 80% Over Comparative Period investment picks
2014/10/31
Spirit AeroSystems Holdings, Inc. Reports Third Quarter 2014 Financial Results; Revenues of $1.7 billion and EPS of $1.20; Raises 2014 Guidance Third Quarter 2014 Consolidated Results and Outlook - Total Revenues of $1.7 billion, up 13% y/y - Fully diluted EPS of $1.20; including $0.30 for the partial release of the deferred tax valuation allowance - Cash Flow From Operations of $119 million, Free Cash Flow of $75 million* - 2014 EPS guidance increased from $2.90 - $3.05 to $3.35 - $3.45 excluding the impact of deferred tax valuation allowance - 2014 Free Cash Flow guidance increased to $275 million* from $250 million* Canada NewsWire WICHITA, Kan.
Sign-up for Spirit AeroSystems Holdings, Inc. Reports Third Quarter 2014 Financial Results; Revenues of $1.7 billion and EPS of $1.20; Raises 2014 Guidance investment picks
2014/10/31
Third Quarter 2014 Consolidated Results and Outlook - Total Revenues of $1.7 billion, up 13% y/y - Fully diluted EPS of $1.20; including $0.30 for the partial release of the deferred tax valuation allowance - Cash Flow From Operations of $119 million, Free Cash Flow of $75 million* - 2014 EPS guidance increased from $2.90 - $3.05 to $3.35 - $3.45 excluding the impact of deferred tax valuation allowance - 2014 Free Cash Flow guidance increased to $275 million* from $250 million* WICHITA, Kan.
Sign-up for Spirit AeroSystems Holdings, Inc. Reports Third Quarter 2014 Financial Results; Revenues of $1.7 billion and EPS of $1.20; Raises 2014 Guidance investment picks
http://media.marketwire.com/attachments/201212/114876_88045_Vert_NoTag.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1153725&ProfileId=051205&sourceType=1 CHICAGO, IL --
Sign-up for Echo Global Logistics Reports Record Third Quarter 2014 Results; Revenue Up 37% Year Over Year investment picks
SAN FRANCISCO , Nov.
Sign-up for Globant Reports Third Quarter Financial Results - Revenue and Earnings Momentum Continues investment picks
Osiris Therapeutics, Inc. (NASDAQ: OSIR), the leading cellular and regenerative medicine company focused on developing and marketing products to treat conditions in wound care, orthopaedic and sports medicine, announced today its financial results for the third quarter of 2014.
Sign-up for Osiris Therapeutics Announces Third Quarter 2014 Financial Results: Revenue up 29% and Company Turned Profitable investment picks

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Results Revenues
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Results Press  |  Next: Results Shows